Pfizer (NYSE:PFE) has decided to raise $3 billion through a part-flotation of its animal health division.

Pfizer Plans $3bn Floatation

According to a Financial Times report, the US based drug maker giant Pfizer (NYSE:PFE) is weighing plans to raise about $3 billion this year through a part-flotation of its animal health division.

The company is in discussions with bankers over an initial public offering that would look to place up to 19.9 percent of the unit’s shares in the autumn.

Pfizer (NYSE:PFE) said that it is still evaluating all options for the division and is set to announce a decision in the coming months.

Pfizer Inc. (NYSE:PFE) stocks are currently standing at 21.19.

Price History
Last Price: 21.19
52 Week Low / High: 16.63 / 22.17
50 Day Moving Average: 21.4
6 Month Price Change %: 19.9%
12 Month Price Change %: 9.4%

Johnson & Johnson (NYSE:JNJ) has recalled Infant’s Tylenol in US due to bottle design problems.

Johnson & Johnson Makes US Tylenol Recall

The pharmaceutical company Johnson & Johnson (NYSE:JNJ) has recalled 574,000 bottles of grape-flavored, liquid Infant’s Tylenol from the US market due to complaints about its bottle design.

The company introduced Infant’s Tylenol three months ago claiming to have made big safety improvements to making measuring doses more accurate.

However, parents complained that when they inserted the syringe into the bottle, it also pushed the protective cover inside.

Johnson & Johnson (NYSE:JNJ) CEO William Weldon said, “Today’s news about the Infant’s Tylenol recall is clearly disappointing after all the progress that McNeil has been making to ensure its products meet the highest level of quality and consumer satisfaction”.

Johnson & Johnson (NYSE:JNJ) stocks were at 64.99 at the end of the last day’s trading. There’s been a 1.8% movement in the stock price over the past 3 months.

Johnson & Johnson (NYSE:JNJ) Analyst Advice
Consensus Opinion: Moderate Buy
Mean recommendation: 2
(1=Strong Buy, 5=Strong Sell)
3 Months Ago: 1.95
Zack’s Rank: 2 out of 14 in the industry

Pfizer (NYSE:PFE) has appointed a new head to lead its Veterinary Business Solutions.

Pfizer Makes Vet Business Change

According to an announcement made by the company, the Animal Health unit of Pfizer (NYSE:PFE) has appointed Steve Sornsen as the new senior director for its Veterinary Business Solutions unit.

In his new role, he will be responsible for leading and implementing efforts for the U.S. Pork Business Unit to help expand veterinary customer relationships.

Gloria Basse, group director, U.S. Pork Business Unit at Pfizer (NYSE:PFE) said, “Steve has always been a great source of leadership and knowledge. With this exciting new role, he will utilize this expertise to develop a wide array of strategic solutions for our veterinary customers. Our goal is to be the complete solutions provider for veterinarians, and Steve will help us achieve this goal.”

Pfizer Inc. (NYSE:PFE) stocks are currently standing at 21.33.

Price History
Last Price: 21.33
52 Week Low / High: 16.63 / 22.17
50 Day Moving Average: 21.35
6 Month Price Change %: 14.2%
12 Month Price Change %: 10.8%

Dow Chemical (NYSE:DOW) Solar has announced the winners of International Design to Zero Competition.

Dow Chemical (NYSE:DOW) Announces Design Competition Winner

Reports say that Dow Chemical Company (NYSE:DOW) has announced the three winning teams of the international Dow Solar Design to Zero Competition at 2012 International Builders’ Show.

These awards show Dow Chemical (NYSE:DOW)’s commitment to support education and innovations that will help solve the world’s challenges.

Pat Nugent, Director of New Business Development, Dow Chemical (NYSE:DOW) Solar, said that, “The students’ designs are perfect examples of the innovative thinking that is needed to create sustainable and energy efficient housing both now and for the future. The Dow Chemical (NYSE:DOW) Solar Design to Zero Competition challenged students to think outside the box to develop net-zero solutions that will ultimately shape the future of sustainable residential building and design; we wanted to share these innovative solutions with the building industries leaders at IBS”.

Dow Chemical (NYSE:DOW) shares are currently standing at 34.42.

Price History
Last Price: 34.42
52 Week Low / High: 20.61 / 42.23
50 Day Moving Average: 30
6 Month Price Change %: 20.7%
12 Month Price Change %: -10.5%

Express Scripts (NASDAQ:ESRX) has received a $2.4 billion prescription drug contract.

Express Scripts (NASDAQ:ESRX) Wins $2.4bn Deal

The Maryland Board of Public Works has awarded a five year contract worth $2.4 billion to the pharmaceutical company Express Scripts (NASDAQ:ESRX) to provide prescription drugs for state employees.

This contract could help the state to save $100 million.

The prescription drug program provides drugs to 219,000 state employees and retirees.

Express Scripts (NASDAQ:ESRX) senior regional director Ron Tyson said, “The contract cost that is expected to save the state $100 million was evaluated as if Walgreens was still there”.

Express Scripts (NASDAQ:ESRX) company shares are currently standing at 50.28.

Price History
Last Price: 50.28
52 Week Low / High: 34.47 / 60.89
50 Day Moving Average: 47.77
6 Month Price Change %: 12.6%
12 Month Price Change %: -10.9%

Dow Chemical (NYSE:DOW) AgroSciences has partnered with PPD in China.

Dow Chemical (NYSE:DOW) Makes PPD Deal

Reports say that Dow Chemical (NYSE:DOW)’s subsidiary Dow AgroSciences has signed a three-year research agreement with BioDuro, PPD’s China-based drug discovery company.

The collaboration aims to generate novel molecules for synthesizing and testing fungicides, insecticides and herbicides across a variety of crops.

Lee Babiss, executive vice president of global laboratory services for PPD, said that, “This collaboration demonstrates BioDuro’s commitment and flexibility in delivering discovery research services beyond the pharmaceutical industry. Combining our strong discovery expertise and first-class technologies with the premier scientists at Dow Chemical (NYSE:DOW) AgroSciences will accelerate discovery and development of novel molecules and advance research for the agrochemical industry”.

Dow Chemical (NYSE:DOW) shares are currently standing at 33.95.

Price History
Last Price: 33.95
52 Week Low / High: 20.61 / 42.23
50 Day Moving Average: 29.81
6 Month Price Change %: 15.3%
12 Month Price Change %: -10.0%

Pfizer (NYSE:PFE) has decided to sell its animal health business unit in India.

Pfizer (NYSE:PFE) Selling Animal Health Unit

The Indian unit of drug maker Pfizer (NYSE:PFE) said that its board has approved the sale of its animal health division to a wholly owned unit for about $90 million.

Pfizer (NYSE:PFE) said in a filing, “The Board of Directors of the company, at its meeting held on February 6, 2012, has approved the sale of its animal health division by way of a slump sale to its wholly-owned subsidiary in consideration of approximately Rs 440 crore ($90 million).”

Pfizer Inc. (NYSE:PFE) stocks are currently standing at 21.05.

Price History
Last Price: 21.05
52 Week Low / High: 16.63 / 22.17
50 Day Moving Average: 21.1
6 Month Price Change %: 25.8%
12 Month Price Change %: 8.6%

Dow Chemical (NYSE:DOW) is reportedly receiving less demand from Europe.

Dow Chemical (NYSE:DOW) Sees Europe Demand Slump

The Midland, Michigan based Multinational Corporation and second largest chemical manufacturer in the world by revenue, Dow Chemical (NYSE:DOW), is reportedly receiving less demand for their products from the European region.

Andrew Liveris, Dow Chemical (NYSE:DOW)’s chief executive, shared his assumption that France and Germany are in recession. He added that he is bullish about the Chinese market and he said that demand from that sector is increasing.

Dow Chemical (NYSE:DOW) company shares are currently standing at 33.54.

Price History
Last Price: 33.54
52 Week Low / High: 20.61 / 42.23
50 Day Moving Average: 29.12
6 Month Price Change %: 0.5%
12 Month Price Change %: -6.7%